vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and OXFORD INDUSTRIES INC (OXM). Click either name above to swap in a different company.
OXFORD INDUSTRIES INC is the larger business by last-quarter revenue ($307.3M vs $168.4M, roughly 1.8× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -0.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -3.0%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.
ESPR vs OXM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $307.3M |
| Net Profit | — | $-63.7M |
| Gross Margin | — | 60.3% |
| Operating Margin | 50.6% | -27.7% |
| Net Margin | — | -20.7% |
| Revenue YoY | 143.7% | -0.2% |
| Net Profit YoY | — | -1517.6% |
| EPS (diluted) | $0.32 | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $307.3M | ||
| Q3 25 | $87.3M | $403.1M | ||
| Q2 25 | $82.4M | $392.9M | ||
| Q1 25 | $65.0M | — | ||
| Q4 24 | $69.1M | $308.0M | ||
| Q3 24 | $51.6M | $419.9M | ||
| Q2 24 | $73.8M | $398.2M | ||
| Q1 24 | $137.7M | $404.4M |
| Q4 25 | — | $-63.7M | ||
| Q3 25 | $-31.3M | $16.7M | ||
| Q2 25 | $-12.7M | $26.2M | ||
| Q1 25 | $-40.5M | — | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $-29.5M | $40.6M | ||
| Q2 24 | $-61.9M | $38.4M | ||
| Q1 24 | $61.0M | $-60.1M |
| Q4 25 | — | 60.3% | ||
| Q3 25 | — | 61.4% | ||
| Q2 25 | — | 64.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 63.1% | ||
| Q3 24 | — | 63.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 60.9% |
| Q4 25 | 50.6% | -27.7% | ||
| Q3 25 | -11.4% | 6.3% | ||
| Q2 25 | 8.6% | 9.2% | ||
| Q1 25 | -34.0% | — | ||
| Q4 24 | -6.4% | -2.0% | ||
| Q3 24 | -31.0% | 12.5% | ||
| Q2 24 | 3.5% | 13.2% | ||
| Q1 24 | 52.5% | -20.1% |
| Q4 25 | — | -20.7% | ||
| Q3 25 | -35.9% | 4.1% | ||
| Q2 25 | -15.4% | 6.7% | ||
| Q1 25 | -62.2% | — | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -57.2% | 9.7% | ||
| Q2 24 | -83.9% | 9.6% | ||
| Q1 24 | 44.3% | -14.9% |
| Q4 25 | $0.32 | $-4.28 | ||
| Q3 25 | $-0.16 | $1.12 | ||
| Q2 25 | $-0.06 | $1.70 | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | $-0.25 | ||
| Q3 24 | $-0.15 | $2.57 | ||
| Q2 24 | $-0.33 | $2.42 | ||
| Q1 24 | $0.34 | $-3.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $8.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $528.0M |
| Total Assets | $465.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $8.0M | ||
| Q3 25 | $92.4M | $6.9M | ||
| Q2 25 | $86.1M | $8.2M | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | $7.0M | ||
| Q3 24 | $144.7M | $18.4M | ||
| Q2 24 | $189.3M | $7.7M | ||
| Q1 24 | $226.6M | $7.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $29.0M |
| Q4 25 | $-302.0M | $528.0M | ||
| Q3 25 | $-451.4M | $597.1M | ||
| Q2 25 | $-433.5M | $592.4M | ||
| Q1 25 | $-426.2M | — | ||
| Q4 24 | $-388.7M | $612.2M | ||
| Q3 24 | $-370.2M | $621.6M | ||
| Q2 24 | $-344.2M | $592.9M | ||
| Q1 24 | $-294.3M | $560.9M |
| Q4 25 | $465.9M | $1.3B | ||
| Q3 25 | $364.0M | $1.3B | ||
| Q2 25 | $347.1M | $1.3B | ||
| Q1 25 | $324.0M | — | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $1.2B | ||
| Q2 24 | $352.3M | $1.2B | ||
| Q1 24 | $373.1M | $1.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-9.1M |
| Free Cash FlowOCF − Capex | — | $-47.9M |
| FCF MarginFCF / Revenue | — | -15.6% |
| Capex IntensityCapex / Revenue | 0.0% | 12.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-79.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-9.1M | ||
| Q3 25 | $-4.3M | $83.5M | ||
| Q2 25 | $-31.4M | $-3.9M | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $-35.0M | $-18.2M | ||
| Q3 24 | $-35.3M | $88.8M | ||
| Q2 24 | $-7.2M | $32.9M | ||
| Q1 24 | $53.8M | $74.9M |
| Q4 25 | — | $-47.9M | ||
| Q3 25 | — | $52.3M | ||
| Q2 25 | — | $-27.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-56.9M | ||
| Q3 24 | $-35.5M | $47.2M | ||
| Q2 24 | $-7.3M | $21.0M | ||
| Q1 24 | $53.8M | $55.3M |
| Q4 25 | — | -15.6% | ||
| Q3 25 | — | 13.0% | ||
| Q2 25 | — | -7.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -18.5% | ||
| Q3 24 | -68.7% | 11.2% | ||
| Q2 24 | -9.9% | 5.3% | ||
| Q1 24 | 39.0% | 13.7% |
| Q4 25 | 0.0% | 12.6% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | 12.6% | ||
| Q3 24 | 0.3% | 9.9% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | 0.1% | 4.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.00× | ||
| Q2 25 | — | -0.15× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.19× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
